Open-label study of a twice-daily indinavir 800-mg/ritonavir 100-mg regimen in protease inhibitor-naive HIV-infected adults.

Source:http://linkedlifedata.com/resource/pubmed/id/12473835

J. Acquir. Immune Defic. Syndr. 2002 Dec 15 31 5 478-82

Download in:

View as

Triples

General Info

PMID
12473835